ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pain Therapeutics Announces Feedback from Recent Meeting With FDA on Remoxy
February 20, 2019Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today announced feedback from a meeting held January 31, 2019 with the U.S. Food and Drug Administration (FDA) regarding the drug candidate.... -
Pain Therapeutics hit with yet another CRL, plots ‘reorganization,’ Alzheimer’s pivot
August 07, 2018With little surprise, Pain Therapeutics has been hit with a complete response letter from the FDA for Remoxy ER, its extended-release, capsule gel form of the opioid oxycodone.
Pharma Sources Insight January 2025
